Nanotech Drugs Reverse Alzheimer’s Symptoms in Mice

An international research team has developed bioactive "supramolecular drugs" to combat Alzheimer's disease ^[1]. These nanoparticles successfully restored the blood-brain barrier in mice models ^[2]. This biological process also rebooted the brain's natural waste-clearing system ^[1].

The study observed a 50 to 60 percent reduction in toxic amyloid proteins in the subjects ^[1]. This significant protein decrease led to the reversal of cognitive symptoms ^[2]. Researchers from the Institute for Bioengineering of Catalonia (IBEC) spearheaded the development ^[2]. While these results are promising, researchers note that further testing is required before human application ^[1][2].